The abstract is read at the publisher; the summary is JClub's.
Population-based MGUS screening in Iceland increased smoldering multiple myeloma detection 27-fold (8.6% vs 0.3%; hazard ratio 27.46) after 4.5 years.
- Why it matters: The clinical and psychological tradeoffs of screening for an asymptomatic precursor are uncertain, especially whether earlier detection creates harm or only benefits.
- What they did: In a nationwide screening study, 75,422 people were tested and 3,541 with MGUS were randomized to no notification, guideline follow-up, or intensified follow-up; outcomes were compared after median 4.5 years.
- The result: Active MM and related malignancies were diagnosed 1 year earlier in notified follow-up arms, with fewer symptomatic presentations and hospitalizations, and MGUS notification showed no adverse psychological outcomes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.